Trial Details

COMPLETED
Basic Information
Clinical ID c1036
Identifier NCT02447302
Trial Title Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: Etrasimod|DRUG: Placebo
Participant Information
Sponsor Arena Pharmaceuticals
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2015-10-15
Primary Completion Date 2018-02-14
Completion Date 2018-02-14